🔴 GRAL is trading 4.7% down today on fresh coverage of securities fraud litigation over Galleri trial disclosures

GRAL is trading 4.7% down at $65.72 following fresh coverage of a securities fraud class action lawsuit tied to its NHS-Galleri trial disclosures.

• The litigation narrative follows a prior sharp selloff triggered by disappointing trial results, as investors focus on the legal implications of the company's disclosures.
• Broader market weakness is exacerbating the move, with the NASDAQ down 1.41% amid softer risk sentiment and no offsetting company news.
• The decline reflects a combination of company-specific legal overhang and a lack of positive catalysts to counter the downward momentum.